Literature DB >> 26976603

Recognition of the disordered p53 transactivation domain by the transcriptional adapter zinc finger domains of CREB-binding protein.

Alexander S Krois1, Josephine C Ferreon1, Maria A Martinez-Yamout1, H Jane Dyson2, Peter E Wright3.   

Abstract

An important component of the activity of p53 as a tumor suppressor is its interaction with the transcriptional coactivators cyclic-AMP response element-binding protein (CREB)-binding protein (CBP) and p300, which activate transcription of p53-regulated stress response genes and stabilize p53 against ubiquitin-mediated degradation. The highest affinity interactions are between the intrinsically disordered N-terminal transactivation domain (TAD) of p53 and the TAZ1 and TAZ2 domains of CBP/p300. The NMR spectra of simple binary complexes of the TAZ1 and TAZ2 domains with the p53TAD suffer from exchange broadening, but innovations in construct design and isotopic labeling have enabled us to obtain high-resolution structures using fusion proteins, uniformly labeled in the case of the TAZ2-p53TAD fusion and segmentally labeled through transintein splicing for the TAZ1-p53TAD fusion. The p53TAD is bipartite, with two interaction motifs, termed AD1 and AD2, which fold to form short amphipathic helices upon binding to TAZ1 and TAZ2 whereas intervening regions of the p53TAD remain flexible. Both the AD1 and AD2 motifs bind to hydrophobic surfaces of the TAZ domains, with AD2 making more extensive hydrophobic contacts consistent with its greater contribution to the binding affinity. Binding of AD1 and AD2 is synergistic, and structural studies performed with isolated motifs can be misleading. The present structures of the full-length p53TAD complexes demonstrate the versatility of the interactions available to an intrinsically disordered domain containing bipartite interaction motifs and provide valuable insights into the structural basis of the affinity changes that occur upon stress-related posttranslational modification.

Entities:  

Keywords:  binding motif; intein; intrinsically disordered protein; segmental labeling; transcriptional coactivator

Mesh:

Substances:

Year:  2016        PMID: 26976603      PMCID: PMC4822595          DOI: 10.1073/pnas.1602487113

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  85 in total

Review 1.  CBP/p300 in cell growth, transformation, and development.

Authors:  R H Goodman; S Smolik
Journal:  Genes Dev       Date:  2000-07-01       Impact factor: 11.361

Review 2.  Assessing TP53 status in human tumours to evaluate clinical outcome.

Authors:  T Soussi; C Béroud
Journal:  Nat Rev Cancer       Date:  2001-12       Impact factor: 60.716

3.  NMRPipe: a multidimensional spectral processing system based on UNIX pipes.

Authors:  F Delaglio; S Grzesiek; G W Vuister; G Zhu; J Pfeifer; A Bax
Journal:  J Biomol NMR       Date:  1995-11       Impact factor: 2.835

Review 4.  p53 ubiquitination: Mdm2 and beyond.

Authors:  Christopher L Brooks; Wei Gu
Journal:  Mol Cell       Date:  2006-02-03       Impact factor: 17.970

5.  Binding of p53 to the KIX domain of CREB binding protein. A potential link to human T-cell leukemia virus, type I-associated leukemogenesis.

Authors:  K Van Orden; H A Giebler; I Lemasson; M Gonzales; J K Nyborg
Journal:  J Biol Chem       Date:  1999-09-10       Impact factor: 5.157

6.  HMGB1-facilitated p53 DNA binding occurs via HMG-Box/p53 transactivation domain interaction, regulated by the acidic tail.

Authors:  John P Rowell; Kathryn L Simpson; Katherine Stott; Matthew Watson; Jean O Thomas
Journal:  Structure       Date:  2012-10-11       Impact factor: 5.006

7.  Structural basis for p300 Taz2-p53 TAD1 binding and modulation by phosphorylation.

Authors:  Hanqiao Feng; Lisa M Miller Jenkins; Stewart R Durell; Ryo Hayashi; Sharlyn J Mazur; Scott Cherry; Joseph E Tropea; Maria Miller; Alexander Wlodawer; Ettore Appella; Yawen Bai
Journal:  Structure       Date:  2009-02-13       Impact factor: 5.006

8.  Structural insights into interactions of C/EBP transcriptional activators with the Taz2 domain of p300.

Authors:  Prasenjit Bhaumik; Jamaine Davis; Joseph E Tropea; Scott Cherry; Peter F Johnson; Maria Miller
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2014-06-29

Review 9.  Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.

Authors:  M S Greenblatt; W P Bennett; M Hollstein; C C Harris
Journal:  Cancer Res       Date:  1994-09-15       Impact factor: 12.701

View more
  35 in total

1.  Long-range regulation of p53 DNA binding by its intrinsically disordered N-terminal transactivation domain.

Authors:  Alexander S Krois; H Jane Dyson; Peter E Wright
Journal:  Proc Natl Acad Sci U S A       Date:  2018-11-12       Impact factor: 11.205

2.  Recognition and targeting mechanisms by chaperones in flagellum assembly and operation.

Authors:  Nandish Khanra; Paolo Rossi; Anastassios Economou; Charalampos G Kalodimos
Journal:  Proc Natl Acad Sci U S A       Date:  2016-08-15       Impact factor: 11.205

3.  Role of Backbone Dynamics in Modulating the Interactions of Disordered Ligands with the TAZ1 Domain of the CREB-Binding Protein.

Authors:  Rebecca B Berlow; Maria A Martinez-Yamout; H Jane Dyson; Peter E Wright
Journal:  Biochemistry       Date:  2019-02-22       Impact factor: 3.162

4.  A phosphorylation-dependent switch in the disordered p53 transactivation domain regulates DNA binding.

Authors:  Xun Sun; H Jane Dyson; Peter E Wright
Journal:  Proc Natl Acad Sci U S A       Date:  2020-12-21       Impact factor: 11.205

5.  A partially disordered region connects gene repression and activation functions of EZH2.

Authors:  Lianying Jiao; Murtada Shubbar; Xin Yang; Qi Zhang; Siming Chen; Qiong Wu; Zhe Chen; Josep Rizo; Xin Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2020-07-06       Impact factor: 11.205

6.  ETV4 and AP1 Transcription Factors Form Multivalent Interactions with three Sites on the MED25 Activator-Interacting Domain.

Authors:  Simon L Currie; Jedediah J Doane; Kathryn S Evans; Niraja Bhachech; Bethany J Madison; Desmond K W Lau; Lawrence P McIntosh; Jack J Skalicky; Kathleen A Clark; Barbara J Graves
Journal:  J Mol Biol       Date:  2017-07-17       Impact factor: 5.469

7.  Elevated expression of p53 in early colon polyps in a pig model of human familial adenomatous polyposis.

Authors:  Krzysztof Flisikowski; Marek Switonski; Agata Sikorska; Tatiana Flisikowska; Monika Stachowiak; Alexander Kind; Angelika Schnieke
Journal:  J Appl Genet       Date:  2018-08-25       Impact factor: 3.240

8.  Structural insights into TAZ2 domain-mediated CBP/p300 recruitment by transactivation domain 1 of the lymphopoietic transcription factor E2A.

Authors:  Marina R Lochhead; Alexandra D Brown; Alyssa C Kirlin; Seth Chitayat; Kim Munro; Jane E Findlay; George S Baillie; David P LeBrun; David N Langelaan; Steven P Smith
Journal:  J Biol Chem       Date:  2020-02-25       Impact factor: 5.157

9.  Intrinsically Disordered Transactivation Domains Bind to TAZ1 Domain of CBP via Diverse Mechanisms.

Authors:  Meng Gao; Jing Yang; Sen Liu; Zhengding Su; Yongqi Huang
Journal:  Biophys J       Date:  2019-08-29       Impact factor: 4.033

Review 10.  Perspective: the essential role of NMR in the discovery and characterization of intrinsically disordered proteins.

Authors:  H Jane Dyson; Peter E Wright
Journal:  J Biomol NMR       Date:  2019-10-15       Impact factor: 2.835

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.